Clinical Trial: A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07634471) titled 'A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)' on June 04.

Brief Summary: Researchers are looking for new ways to treat follicular lymphoma (FL). A standard (usual) treatment for FL includes a targeted therapy called rituximab and chemotherapy. In this study, researchers want to learn if giving a study medicine called MK-1045 and rituximab can treat FL. MK-1045 is a type of treatment called immunotherapy.

The goals of this study are to learn:

* About the safety of MK-1045 and rituximab, and if people tolerate them when given together

* If people who receive MK-1045 and rituximab have th...